Immune Design Cash Flow - Quarterly (NASDAQ:IMDZ)

Add to My Stocks
$3.4 $0.1 (2.86%) IMDZ stock closing price Sep 24, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Immune Design needs to disclose. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Immune Design profits and Immune Design debt. Immune Design had cash and cash equivalents of $45.21M at beginning of the quarter and $73.63M at quarter end of 2018 Q2. Immune Design cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Immune Design saw a inflow of $21.92M from investing activities till 2018 Q2.

View and download details of Immune Design cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-0.1M-0.06M--------
Net Increase (Decrease) in Assets Liabilities-4.33M-5.75M-10.15M-10.24M-4.25M-7.11M8.07M-1.5M-2.2M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net4.24M2.73M8.63M6.6M4.45M2.24M9.28M6.9M4.58M2.33M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.24M-0.2M-0.42M-0.34M-0.26M-0.2M-0.13M-0.07M-0.05M-0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments22.16M10.07M-6.61M26.03M16M--62.28M-42M-42M-46M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--87.33M---30.45M30.94M--
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year45.21M112.92M75.35M30.38M12.76M12M12M---
Cash & Equivalents at Year End73.63M72.37M72.45M28.36M35.31M27.91M45.21M70.43M50.53M54.76M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Immune Design stock price history provides insight into historical stock price fluctuations, and Immune Design stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Immune Design saw a positive change in Net Change in Cash and Cash Equivalents of $-5.02M till 2018 Q2. Apart from the Immune Design stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-27.3M for IMDZ.
  • Cash Flow from investment activities: Immune Design generated $21.92M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for Immune Design. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Immune Design Cash Flow